Mike Wood MP: speeches

Speeches

• 15 Sept 2026 · Sepsis Awareness Month · Hansard source

  More

  I beg to move, That this House has considered World Sepsis Awareness Month. As co-chair of the all-party parliamentary group on sepsis, I would like to begin by expressing my gratitude to the Backbench Business Committee for granting time for this debate. To the best of my knowledge, this is the very first debate in the House of Commons Chamber dedicated to sepsis. In the past, this devastating condition has been discussed only in Westminster Hall debates or raised through brief interventions and questions. Having sepsis debated on the Floor of the main Chamber during Sepsis Awareness Month is a major milestone, not only for Parliament but for the clinicians, charities and bereaved families across the country who have campaigned tirelessly to bring this condition out of the shadows. I would also like to thank the co-sponsors of this debate: the hon. Member for Ashfield (Lee Anderson), who cannot be here this afternoon but who led an important Westminster Hall debate on this subject two years ago, and the hon. Member for Dartford (Jim Dickson), vice-chair of the APPG. Sepsis strikes indiscriminately, ruthlessly and with terrifying speed, without regard for background, class or, indeed, political allegiance. It is vital that we all stand united in our determination to tackle this deadly condition. It is a challenge that completely transcends party politics. On Sunday, communities across the world marked World Sepsis Day. The international theme for this year could not be more apt: “Invest in Sepsis—Save Lives.” The World Health Organisation recognises sepsis as one of the leading causes of death and disability globally, estimating that sepsis-related illnesses account for one in every five deaths worldwide. In the United Kingdom, NHS England has made it clear that sepsis claims more lives each year than lung cancer and represents the second biggest killer in our hospitals after cardiovascular disease. Every single year, an estimated 245,000 people in the UK develop sepsis and, tragically, more than 48,000 lose their lives. That is a higher annual death toll than bowel, breast and prostate cancers combined. Behind every one of those figures is a family left grieving and asking the same agonising question: what if? What if the symptoms had been recognised an hour earlier? What if antibiotics had been administered sooner? What if someone had simply asked, “Could it be sepsis?”? Madam Deputy Speaker, as you know, I do not approach this debate purely as a parliamentarian dispassionately analysing policy responses to one of the leading causes of avoidable death. I stand in this Chamber today because almost a decade ago, by the grace of God and the extraordinary skill and care of NHS staff, my life was saved. In January 2017, I was a relatively fit and active 40-year-old Member of Parliament. I had developed what I assumed was merely a winter infection. Like many people would, I assumed that I could push through it, take some paracetamol and carry on working. I travelled out to Strasbourg to take part in the Parliamentary Assembly of the Council of Europe on the Sunday evening, but within days my condition collapsed. An ordinary throat infection triggered a catastrophic immune response. My body, in attempting to fight the infection, began attacking its own tissues and organs. By Thursday, after seeing a French GP, I flew back to Britain. On Friday, I attended the official launch of the local enterprise zone that I had campaigned hard for in my constituency, but as soon as I arrived there I was so ill that I had to rest in the back room. On Saturday morning, I got out of bed, started putting my suit on over my pyjamas and told my wife Laura that I had to come down to Westminster to vote. Like many in politics, my behaviour can at times appear to some people to be a little idiosyncratic; fortunately, Laura realised that, even for a Member of Parliament, that was not entirely normal behaviour. Laura rushed me to Russells Hall hospital in Dudley, where my blood pressure plummeted into septic shock and my organs began shutting down. My life was hanging by a thread. The medical team had to place me in a medically induced coma. Doctors told my family that my chances of pulling through were no better than one in 10. For 11 days, I lay in intensive care on life support—or, as my family sometimes remind me, I slept through the difficult bits. When I did finally wake up, my muscles had wasted away—I could barely lift my arms, let alone stand or walk—but it could easily have been so much worse. What if Laura had left me to get some rest that Saturday morning while she took our daughter to her dance class? Above all, what if the nurse who examined me at the accident and emergency department had not had the insight to check whether the symptoms, which could easily have been mistaken for other illnesses such as flu or meningitis, might be sepsis? I owe a debt of gratitude to the doctors, intensive care nurses and other staff at Russells Hall hospital that I can never repay, but as long as I have the honour of serving in this House, I will use my voice to fight for sepsis patients and their families. There is a common misconception that sepsis is primarily the result of hospital-acquired infection, but the evidence demonstrates the exact opposite. A major 2024 population study led by Professor van Staa, analysing linked primary care and hospital data in England, showed that the vast majority of sepsis cases are community acquired, developing in homes, workplaces and local communities long before a patient reaches an acute hospital bed. That research also uncovered deep health inequalities in sepsis risk. The risk of developing sepsis is significantly heightened by socioeconomic deprivation, by frailty, by being housebound and by chronic conditions such as cancer, diabetes and learning disabilities. Exposure to antibiotics in the previous two months was also identified as a strong risk factor. While ethnicity was not an independent biological factor, black and Asian individuals suffer from a higher prevalence of predisposing conditions including diabetes, chronic liver disease and severe anaemia, which puts them at a greater risk, so tackling sepsis is not merely a technical, clinical issue but a fundamental challenge of health inequality and community prevention. One of the most critical clinical lessons learned in recent years is the direct link between viral infections and sepsis. For decades, the public and the medical community viewed sepsis almost exclusively as a bacterial complication, but the covid-19 pandemic demonstrated that viral infections can trigger the exact same catastrophic septic response. The overwhelming cytokine storms, microvascular clotting and rapid progression to acute respiratory distress syndrome and multi-organ failure seen in covid intensive care units are classic manifestations of viral sepsis. It is thought by many experts in the field that the vast majority of covid deaths were a direct result of septic reactions. Sepsis is not defined by the pathogen; it is defined by the body’s life-threatening immune reaction to any severe infection, whether bacterial, viral or fungal. That reality extends directly into long-term recovery: millions who had covid-19 are still living with long covid. Sepsis survivors have known that reality for generations under the name of post-sepsis syndrome. In my case, it is little more than some nerve damage and tiredness, even a decade later, but for many the symptoms are more severe. Up to 50% of sepsis survivors suffer prolonged physical, cognitive and psychological impairments from debilitating fatigue and cognitive brain fog to severe muscle weakness and post-traumatic stress disorder. The clinical insights gained from viral sepsis during the pandemic must now be used to build integrated recovery pathways for all sepsis survivors. To curb preventable deaths, a health system must act decisively in several areas; in the interests of time, I will go through just four. First, the system must ensure consistent rapid recognition. Time is the single most decisive factor in sepsis survival. Clinical research shows that administering appropriate antibiotics within the first hour of a patient presenting to an emergency department with sepsis reduces the risk of death by a full one third compared with delayed treatment. Secondly, the system must ensure that where sepsis is suspected, appropriate clinical escalation pathways are in place. Where sepsis is suspected, early warning systems such as the national early warning score 2, or NEWS2, have saved countless lives, and the ongoing roll-out of Martha’s rule across NHS trusts, which has already saved thousands of lives, is vital in ensuring that patients and loved ones can trigger an immediate independent critical review when they sense deterioration. Thirdly, we must take advantage of innovation in rapid diagnostics. We know that administering broad-spectrum antibiotics within the golden hour that I spoke of massively increases survival rates, but clinicians often face the dilemma of judging whether that is compatible with responsible antimicrobial stewardship. Deploying rapid molecular diagnostics, bedside biomarker technologies and wearable continuous physiological monitors can remove that guesswork, and provide targeted care before septic shock takes hold and it can be too late. Fourthly, although Britain has in many ways led the way in developing and enhancing sepsis care and treatment, we must be open to learning from established international models and practices. Sweden utilises standard sepsis alerts to prioritise patients at triage, and implements mandatory post-discharge telephone follow-ups. France, where I was when I was taken ill, has since introduced an integrated national sepsis plan spanning pre-hospital recognition, emergency pathways and structured rehabilitation to help patients return to employment. Australia established a national sepsis clinical care standard built around seven quality statements, ensuring end-to-end consistency from triage through to survivorship. The publication in July of the sepsis modern service framework by NHS England and the Department of Health and Social Care is an important step towards doing that and learning the lessons from around the world; I warmly welcome it. The framework is one of the first to be published under the 10-year health plan. Its headline goal, “to reduce deaths, severe complications and long-term harm from sepsis…by at least 25% by 2035” is a target that every member of this House can endorse.

• 15 Sept 2026 · Sepsis Awareness Month · Hansard source

  More

  The hon. Lady makes a really important point. We know how these conditions can come round in a cycle. In order to break that cycle, we will need multiple years of vaccination. The modern service framework contains a number of vital commitments, but I particularly welcome: action 4 on improving the audit and feedback of sepsis-related clinical data across trusts; action 5 on updating training for NHS staff, social care workers and unpaid carers; action 9 on optimising care pathways and expanding access to rapid diagnostics and specialist advice; action 11 on standardising digital specifications for early warning systems such as NEWS2; and action 12 on reviewing and addressing capacity gaps in critical and enhanced care. A strategy on paper will not be enough to save a deteriorating patient on a cold winter weekend in an overcrowded emergency department. In the other place, my noble friend and our former colleague Lord Mackinlay of Richborough, who has spoken with enormous courage about his own life-altering encounter with sepsis, has repeatedly tabled written questions seeking clarity on how this framework will be delivered. Regrettably, the answers provided by Ministers in the Lords to date have been rather generic and vague, and lacking in operational detail. We cannot accept boilerplate responses on a condition that kills 48,000 people each year, so I have two direct questions that I hope the Minister will answer in her response to today’s debate. First, what are the specific milestone-driven timelines for the delivery of each of the actions set out in the modern service framework, and when will trusts and integrated care boards be expected to have these standardised pathways fully operational? Secondly, can the Minister assure the House that the Department of Health and Social Care is prepared to commit the dedicated investment required to make this framework work? When we call for investment, we must be clear that funding sepsis care is not an open-ended cost. It is one of the most cost-effective investments that the Department can make. Sepsis currently places an enormous financial burden on the national health service and the wider economy. Too often, cases of missed or delayed diagnosis and treatment result in weeks of high-cost intensive care unit admissions, in emergency readmissions due to incomplete recovery, in complex surgical interventions including amputations requiring lifelong prosthetic and social care support, or in the permanent loss of working-age adults from the workforce. Investing in rapid bedside diagnostics, digital early warning systems, specialist outreach teams and structured post-sepsis rehabilitation can dramatically reduce the lengths of stay in intensive care, lower readmission rates and keep people in work. Early intervention is not only clinically imperative; it is economically sound, and the theme “Invest in sepsis—save lives” is a call for smart preventive healthcare investment.

• 10 Sept 2026 · No. 10 North · Hansard source

  More

  We would not have had to table so many written questions if Ministers had actually answered our first question, instead of expecting us to come up with precisely the right form of words to leave them with no way of getting out. Surely it cannot be right that it requires a freedom of information request to discover how much it costs for a replica door at No. 10 North, but the Minister refuses to answer legitimate parliamentary scrutiny. Will the Minister at least—if he does have this information, which the Department surely does—finally commit to publishing the total budget for No. 10 North, the number of staff and special advisers who are going to work there, and attendance statistics?

• 2 Sept 2026 · EU Membership Referendum: Impact on the UK · Hansard source

  More

  It is a pleasure to serve under your chairship, Ms Butler, and to respond on behalf of His Majesty’s official Opposition. I congratulate the hon. Member for Perth and Kinross-shire (Pete Wishart) on securing this debate, but I am sure it will come as no surprise to him or other hon. Members that we see the legacy of the 2016 referendum, and indeed the path forward for our country, through a very different lens. Listening to the hon. Gentleman, one might almost assume that the United Kingdom was a sunlit, frictionless economic Shangri-La until a single ballot paper cast us into eternal ruin. He told us, echoed by other hon. Members, that leaving the European Union uniquely crippled our economy and that our only salvation lies in surrendering sovereignty through the Government’s grandly titled EU reset, or perhaps going further. That entire narrative collapses under the weight of hard economic reality. First, let us examine the great myth of the EU single market as an automatic engine of export growth. Ministers speak of the single market as if it were a place where magic happens, but if there was magic, the UK was firmly in the audience wondering when the rabbit would emerge from the hat. As former Trade and Industry Secretary Lord Lilley demonstrated in his Policy Exchange paper earlier this year, during our entire 28-year membership of the single market, from 1992, UK goods exports to our EU partners grew by less than 1% per year, but over that exact same period our goods exports to the 111 countries with which we traded on standard World Trade Organisation terms grew by 87%. In fact, according to the European Commission’s own single market scoreboard, the UK was the member state that benefited least from the goods single market. Rejoining that regulatory straitjacket in pursuit of export growth is the pure triumph of hope over experience. Secondly, we must address the sheer statistical alchemy deployed by advocates of rejoining. Several speakers have brandished a non-peer-reviewed National Bureau of Economic Research working paper that claims that Brexit cost the UK up to 8% of GDP, but let us look at how the model has constructed that parallel universe. It created a statistical doppelganger proxy that was dominated by the United States and Estonia, which between them provide almost three quarters of the entire weighting for the alternative proxies—apparently—for where the UK could have been without Brexit. It assumed that, had we remained in the EU, the UK would have miraculously mirrored the American economic performance. To attribute that divergence to Brexit requires an extraordinary leap of imagination. It requires one to pretend that there was no US artificial intelligence boom, no massive American fiscal stimulus—which was possible because the dollar is the world’s reserve currency—no transatlantic shale gas price advantage, no differing pandemic shock, and no North sea oil rundown. In fact, Germany fell 8% behind the same arbitrary index under that model, so unless German departure from the EU has passed us by unnoticed, blaming that divergence on Brexit is simply economic nonsense. When we examine the actual data, rather than econometric fairy tales, the evidence is clear. Between 2016 and 2025, the UK economy grew by 12.2%, and by 5.3% since we formally left, outpacing the European G7 average. Since Brexit, British economic growth has averaged 1.1% per annum, compared with just 0.1% for Germany. As hon. Members have mentioned, the Office for Budget Responsibility previously assumed an implausible 15% collapse in total UK global trade openness, but as its own November 2025 briefing conceded, UK trade intensity has remained stable at around 65% of GDP and has continued to track peer economies such as France. The single market was overwhelmingly designed for goods, but more than 80% of the UK economy is based on services. Our services exports continue to boom globally. Even the dire predictions of a mass exodus from the City of London proved dramatically overblown. Institutions such as JP Morgan, which had threatened to move thousands of jobs abroad, have instead been transferring staff back from Paris to London. Although business investment was undeniably delayed during the post-2016 political paralysis, dragged out by those trying to overturn the referendum, fixed investment to GDP rebounded, reaching 19.6% by the end of last year.

• 2 Sept 2026 · EU Membership Referendum: Impact on the UK · Hansard source

  More

  If we chart it over the last two decades, particularly against German performance, on almost any economic chart we look at, it would be almost impossible to pick out the point at which the UK left the European Union. It is impossible to say from looking at those charts that our economy has grown more slowly than Germany’s, because it has not; it has grown more quickly. Our trade has not been disrupted more than Germany’s— [ Interruption. ] It really has not; they track almost identically across that chart. Thirdly, where Britain is succeeding, we are doing so precisely because of our post-Brexit freedoms. The UK digital and tech flat white economy now represents about 15% of GDP—larger than the entire domestic goods sector. As the Growth Commission highlighted, our tech sector is flourishing and leading Europe in artificial intelligence, precisely because it is unburdened by Brussels’ heavy-handed Digital Markets Act, Digital Services Act and restrictive AI Act. Instead of backing British enterprise, the Government are proposing to pursue unilateral dynamic alignment, shackling the 92% of British firms that do not trade with the EU to Brussels’s rulebook, surrendering our precision breeding advantages and hiking domestic carbon costs by linking our emissions trading scheme, which threaten to add up to £100 per tonne to fertiliser prices at a time when they are already crippling British farmers, while paying administrative fees to Brussels for the privilege. That is an astonishingly one-sided bargain, a masterclass in the art of the bad deal. The lesson of the past 10 years is that national prosperity is built by businesses working across the UK, not subcontracted to the EU. The economic catastrophe prophesied in 2016 simply did not occur.